All coverage
New Alzheimer's drug slows disease by a third
By James Gallagher
Study: Lilly Alzheimer's therapy slowed patients' cognitive decline
By Adam Feuerstein & Matthew Herper
Experimental Alzheimer’s drug slows cognitive declines in large trial, drugmaker Eli Lilly says
By Meg Tirrell
Lilly drug slows Alzheimer's by 35%, bolstering treatment approach
By Julie Steenhuysen & Deena Beasley